Abstract
Androgen receptor (AR)-gene amplification, found in 20-30% of castration-resistant prostate cancer (CRPCa) is proposed to develop as a consequence of hormone-deprivation therapy and be a prime cause of treatment failure. Here we investigate AR-gene amplification in cancers before hormone deprivation therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1655-1662 |
| Number of pages | 8 |
| Journal | British Journal of Cancer |
| Volume | 110 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 18 Mar 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Profiles
-
Daniel Brewer
- Norwich Medical School - Professor in Medical Bioinformatics and Genomics
- Metabolic Health - Member
- Cancer Studies - Member
Person: Research Group Member, Research Centre Member, Academic, Teaching and Research
-
Colin Cooper
- Norwich Medical School - Professor of Cancer Genetics
- Metabolic Health - Member
- Cancer Studies - Member
Person: Research Group Member, Research Centre Member, Academic, Teaching and Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver